Vivus' Race Against The Clock
Vivus is getting the JPMorgan Healthcare Conference off to a sexy start.
The company announced this morningthat its late-stage experimental erectile dysfunction drug apparently gets the job done in 15 minutes.
Depending on the dosage, 67-72 percent of men in the study said they were ready to do it within a quarter hour. That's way faster than Pfizer's Viagra, Lilly's Cialis and Levitra from GlaxoSmithKline, Merck and Bayer.
Vivus officials call those results "surprising."
The company plans to file for FDA approval of the pill by the end of this year. It recently filed for the agency okay of its diet drug Qnexa. Arena Pharmaceuticals is also seeking regulatory approval of a weightloss pill. Orexigen is expected to submit its application soon for a third diet pill.
Finally, it looks like the coach of my USC Trojans will be going to work for billionaire biotech backer and Seattle Seahawks owner Paul Allen. I am not joining the chorus of boo-birds that thinks Pete Carroll has betrayed them. Sure, I hope his bolting doesn't mean the SC football program is on the verge of getting into trouble with the NCAA, but this is the nature of the beast and the business. So, thank you, Coach, for a decade of college football dominance, great times and fantastic memories. All the best in Seattle. Fight On!
Questions? Comments? Pharma@cnbc.com and follow me on Twitter at mhuckman